Kaitlyn Warias2023-12-04T18:30:44+00:00Accelerating Innovation: IP&C’s Eighth Annual Proof of Principle Competition Awards $300,000 to Outstanding SickKids’ ProjectsKaitlyn Warias2023-12-04T18:30:44+00:00December 4th, 2023|
Kaitlyn Warias2023-09-11T17:16:54+00:00A designer peptide against the EAG2–Kvβ2 potassium channel targets the interaction of cancer cells and neurons to treat glioblastomaKaitlyn Warias2023-09-11T17:16:54+00:00September 11th, 2023|
Anny Song2023-10-16T19:11:26+00:00A multi-specific, multi-affinity antibody platform neutralizes sarbecoviruses and confers protection against SARS-CoV-2 in vivoAnny Song2023-10-16T19:11:26+00:00May 26th, 2023|
Anny Song2023-04-25T14:34:08+00:00Radiant Biotherapeutics Emerges from Stealth Mode with $8 Million Seed Round and Two Pharma PartnershipsAnny Song2023-04-25T14:34:08+00:00April 25th, 2023|
Anny Song2023-03-22T02:52:51+00:00Novel machine-learning algorithm creates atlas of cancer with potential as universal diagnostic platformAnny Song2023-03-22T02:52:51+00:00March 22nd, 2023|
Anny Song2022-11-29T04:15:51+00:00Researchers develop novel algorithm to unlock role of cellular phenomenon in aggressive cancersAnny Song2022-11-29T04:15:51+00:00November 29th, 2022|
